KontRASt-02: A phase III trial investigating the efficacy and safety of the KRAS(G12C) inhibitor JDQ443 vs docetaxel in patients with previously treated, locally advanced or metastatic, KRAS G12C-mutated NSCLC
Refereed conference paper presented and published in conference proceedings


Times Cited
Web of Science3WOS source URL (as at 19/08/2024) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListCappuzzo F, Castro G, Kang JH, Wu YL, Brustugun OT, Cheema PK, Owonikoko TK, Longin AS, Boran A, Duan J, Caparica R, Loong HHF
Name of Conference2023 ASCO Annual Meeting I
Start Date of Conference02/06/2023
End Date of Conference06/06/2023
Place of ConferenceChicago
Country/Region of ConferenceUnited States of America
Proceedings TitleJournal of Clinical Oncology
Title of PublicationJOURNAL OF CLINICAL ONCOLOGY
Year2023
Month6
Volume Number41
Issue Numbersuppl. 16
PublisherLIPPINCOTT WILLIAMS & WILKINS
Article numberTPS9144
ISSN0732-183X
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology;Oncology

Last updated on 2024-20-08 at 00:35